Periodontal Therapeutics Market is expected to reach US$ 808.81 Mn. at a CAGR of 5.26 during the forecast period 2029. The Periodontal diseases are infections of the structure around the teeth, which includes the gums, periodontal ligament and alveolar bone. Periodontal therapeutics are products used in the treatment and diagnosis of periodontal diseases. These products include antibiotics like minocycline, metronidazole, doxycycline, and amoxicillin and locally used antibiotics like atridox, arestin, and periochip.To know about the Research Methodology :- Request Free Sample Report These antibiotics can either be directed to patients orally or delivered directly to dental pockets, without systemic doses.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.
Periodontal Therapeutics Market Drivers and Restrains
Problem of periodontal disease is a key factor driving the periodontal therapeutics market. Periodontal diseases are of two types such as periodontitis and gingivitis. Periodontal diseases are prevalent in developed and developing countries, affect around xx % of the global population. The global burden of disease study shown over a time span of 20 years and states that severe periodontitis is one of the most predominant diseases across the world. It has frequency of around xx % and approximately xx million people are affected by it worldwide. In recent studies problem of periodontal diseases worldwide has greater than before by nearly xx% from 2018 to 2022 year. Periodontitis a major cause of tooth loss in the adult population across the world i.e., major risk of getting masticatory, edentulous dysfunction and multiple tooth loss. Reasons behind these are affects nutrition, self-esteem, quality of life, and imposes high health care and significant socio-economic costs. Growth in number of diabetic patients across the globe is also backing to the expansion of the market in terms of profit. According to the American Academy of Periodontology (AAP), perople with diabetes are further susceptible to have periodontal diseases, because of the fact that individuals having diabetes are more likely to contract infections. Increasing global burden of diabetes is expected to grow the number of patient with periodontal diseases during the forecast period.Manufacturers in the Periodontal Therapeutics are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.Periodontal Therapeutics Market Segmentation Analysis
The periodontal therapeutics market is segregated based on type, treatment, end user, and region. In terms of type, the periodontal therapeutics market is segmented into gingivitis, chronic periodontitis, aggressive periodontitis, necrotizing periodontal disease. By end users market is segmented into dental clinics, hospital and others. In terms of treatment market is segmented into systematic antibiotics, local antibiotics and others. Systematic antibiotics are further sub-segmented into doxycycline, minocycline, metronidazole, and others. Local antibiotics are sub segmented into arestin, chlorhexidine, and others. In terms of treatment local antibiotics and systematic antibiotics segment is expected to exhibit highest global market share at a CAGR of xx % over forecast period.Periodontal Therapeutics Market Regional Analysis
On the basis of region Periodontal Therapeutics Market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, North America had hold the largest market share in 2018 and is projected to lead the market during the forecast period. Because of Initiatives by local governments to improve oral care, especially for persons suffering from untreated dental diseases and provision of knowledgeable dental workforce to address the large unmet needs are projected to drive the market in the region. Asia Pacific is expected to be the second largest market over the forecast period and nearly follow by North America in terms of profits. Because of exponential rise in the geriatric population and increase in awareness among consumers regarding dental health. The objective of the report is to present comprehensive analysis of Periodontal Therapeutics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Periodontal Therapeutics Market dynamics, structure by analyzing the market segments, and project the Periodontal Therapeutics Market size. Clear representation of competitive analysis of key players by Periodontal Therapeutics Type, price, financial position, product portfolio, growth strategies, and regional presence in the Periodontal Therapeutics Market make the report investor’s guide.Scope of the Global Periodontal Therapeutics Market: Inquire before buying
Global Periodontal Therapeutics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 564.9 Mn. Forecast Period 2023 to 2029 CAGR: 5.26% Market Size in 2029: US $ 808.81 Mn. Segments Covered: by Treatment Systematic Antibiotics Local Antibiotics Others by Type Gingivitis Chronic periodontitis Aggressive periodontitis Necrotizing periodontal disease by End Users Dental clinics Hospital Periodontal Therapeutics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Periodontal Therapeutics Market Key Players are:
1. 3M 2. Den-Mat Holdings, LLC 3. Dexcel Pharma 4. Galderma S.A. 5. Kaken Pharmaceutical Co., Ltd. 6. Valeant Pharmaceuticals International, Inc 7. OASIS Medical 8. AFT Pharmaceuticals 9. I-Med Pharma Inc. 10.Dentsply Sirona 11.Biohorizons 12.Dexcel Pharma 13.Zimmer Biomet, 14.Emergent Biosolutions, Inc. 15.F. Hoffmann-La Roche Ltd. 16.Gilead Sciences 17.Inovio Pharmaceuticals 18.Novavax, Inc. 19.SELLAS Life Sciences Group, Inc 20.Tolmar Pharmaceuticals, Inc. 21.Eli Lilly and Company 22.Align Technology, Inc. 23.Ultradent Products Inc. 24.Nobel Biocare Services AG 25.Glidewell Laboratories 26.Mallinckrodt.Frequently Asked questions
1. What is the market size of the Global Periodontal Therapeutics Market in 2022? Ans. The market size Global Periodontal Therapeutics Market in 2022 was US$ 564.9 Million. 2. What are the different segments of the Global Periodontal Therapeutics Market? Ans. The Global Periodontal Therapeutics Market is divided into Treatment, Type and End Users. 3. What is the study period of this market? Ans. The Global Periodontal Therapeutics Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Periodontal Therapeutics Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Periodontal Therapeutics Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Periodontal Therapeutics Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Periodontal Therapeutics Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Periodontal Therapeutics Market Analysis and Forecast 6.1. Global Periodontal Therapeutics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Periodontal Therapeutics Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Periodontal Therapeutics Market Value Share Analysis, by Type 7.4. Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Type 7.5. Global Periodontal Therapeutics Market Analysis, by Type 7.6. Global Periodontal Therapeutics Market Attractiveness Analysis, by Type 8. Global Periodontal Therapeutics Market Analysis and Forecast, by Treatment 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Periodontal Therapeutics Market Value Share Analysis, by Treatment 8.4. Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Treatment 8.5. Global Periodontal Therapeutics Market Analysis, by Treatment 8.6. Global Periodontal Therapeutics Market Attractiveness Analysis, by Treatment 9. Global Periodontal Therapeutics Market Analysis and Forecast, by End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Periodontal Therapeutics Market Value Share Analysis, by End-User 9.4. Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by End-User 9.5. Global Periodontal Therapeutics Market Analysis, by End-User 9.6. Global Periodontal Therapeutics Market Attractiveness Analysis, by End-User 10. Global Periodontal Therapeutics Market Analysis, by Region 10.1. Global Periodontal Therapeutics Market Value Share Analysis, by Region 10.2. Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region 10.3. Global Periodontal Therapeutics Market Attractiveness Analysis, by Region 11. North America Periodontal Therapeutics Market Analysis 11.1. Key Findings 11.2. North America Periodontal Therapeutics Market Overview 11.3. North America Periodontal Therapeutics Market Value Share Analysis, by Type 11.4. North America Periodontal Therapeutics Market Forecast, by Type 11.4.1.1. Gingivitis 11.4.1.2. Chronic periodontitis 11.4.1.3. Aggressive periodontitis 11.4.1.4. Necrotizing periodontal disease 11.5. North America Periodontal Therapeutics Market Value Share Analysis, by Treatment 11.6. North America Periodontal Therapeutics Market Forecast, by Treatment 11.6.1. Systematic Antibiotics 11.6.2. Local Antibiotics 11.6.3. Others 11.7. North America Periodontal Therapeutics Market Value Share Analysis, by End-User 11.8. North America Periodontal Therapeutics Market Forecast, by End-User 11.8.1. Dental clinics 11.8.2. Hospital 11.9. North America Periodontal Therapeutics Market Value Share Analysis, by Country 11.10. North America Periodontal Therapeutics Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Periodontal Therapeutics Market Analysis, by Country 11.12. U.S. Periodontal Therapeutics Market Forecast, by Type 11.12.1.1. Gingivitis 11.12.1.2. Chronic periodontitis 11.12.1.3. Aggressive periodontitis 11.12.1.4. Necrotizing periodontal disease 11.13. U.S. Periodontal Therapeutics Market Forecast, by Treatment 11.13.1. Systematic Antibiotics 11.13.2. Local Antibiotics 11.13.3. Others 11.14. U.S. Periodontal Therapeutics Market Forecast, by End-User 11.14.1.1. Dental clinics 11.14.1.2. Hospital 11.15. Canada Periodontal Therapeutics Market Forecast, by Type 11.15.1.1. Gingivitis 11.15.1.2. Chronic periodontitis 11.15.1.3. Aggressive periodontitis 11.15.1.4. Necrotizing periodontal disease 11.16. Steel Canada Periodontal Therapeutics Market Forecast, by Treatment 11.16.1. Systematic Antibiotics 11.16.2. Local Antibiotics 11.16.3. Others 11.17. Canada Periodontal Therapeutics Market Forecast, by End-User 11.17.1. Dental clinics 11.17.2. Hospital 11.18. North America Periodontal Therapeutics Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By Treatment 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Periodontal Therapeutics Market Analysis 12.1. Key Findings 12.2. Europe Periodontal Therapeutics Market Overview 12.3. Europe Periodontal Therapeutics Market Value Share Analysis, by Type 12.4. Europe Periodontal Therapeutics Market Forecast, by Type 12.4.1.1. Gingivitis 12.4.1.2. Chronic periodontitis 12.4.1.3. Aggressive periodontitis 12.4.1.4. Necrotizing periodontal disease 12.5. Europe Periodontal Therapeutics Market Value Share Analysis, by Treatment 12.6. Europe Periodontal Therapeutics Market Forecast, by Treatment 12.6.1. Systematic Antibiotics 12.6.2. Local Antibiotics 12.6.3. Others 12.7. Europe Periodontal Therapeutics Market Value Share Analysis, by End-User 12.8. Europe Periodontal Therapeutics Market Forecast, by End-User 12.8.1. Dental clinics 12.8.2. Hospital 12.9. Europe Periodontal Therapeutics Market Value Share Analysis, by Country 12.10. Europe Periodontal Therapeutics Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Periodontal Therapeutics Market Analysis, by Country 12.12. Germany Periodontal Therapeutics Market Forecast, by Type 12.12.1.1. Gingivitis 12.12.1.2. Chronic periodontitis 12.12.1.3. Aggressive periodontitis 12.12.1.4. Necrotizing periodontal disease 12.13. Germany Periodontal Therapeutics Market Forecast, by Treatment 12.13.1. Systematic Antibiotics 12.13.2. Local Antibiotics 12.13.3. Others 12.14. Germany Periodontal Therapeutics Market Forecast, by End-User 12.14.1. Dental clinics 12.14.2. Hospital 12.15. U.K. Periodontal Therapeutics Market Forecast, by Type 12.15.1.1. Gingivitis 12.15.1.2. Chronic periodontitis 12.15.1.3. Aggressive periodontitis 12.15.1.4. Necrotizing periodontal disease 12.16. U.K. Periodontal Therapeutics Market Forecast, by Treatment 12.16.1. Systematic Antibiotics 12.16.2. Local Antibiotics 12.16.3. Others 12.17. U.K. Periodontal Therapeutics Market Forecast, by End-User 12.17.1. Dental clinics 12.17.2. Hospital 12.18. France Periodontal Therapeutics Market Forecast, by Type 12.18.1.1. Gingivitis 12.18.1.2. Chronic periodontitis 12.18.1.3. Aggressive periodontitis 12.18.1.4. Necrotizing periodontal disease 12.19. France Periodontal Therapeutics Market Forecast, by Treatment 12.19.1. Systematic Antibiotics 12.19.2. Local Antibiotics 12.19.3. Others 12.20. France Periodontal Therapeutics Market Forecast, by End-User 12.20.1. Dental clinics 12.20.2. Hospital 12.20.3. Logistics 12.20.4. Aerospace 12.20.5. Defense 12.20.6. Consumer electronics 12.20.7. Healthcare 12.20.8. Medical devices 12.21. Italy Periodontal Therapeutics Market Forecast, by Type 12.21.1.1. Gingivitis 12.21.1.2. Chronic periodontitis 12.21.1.3. Aggressive periodontitis 12.21.1.4. Necrotizing periodontal disease 12.22. Italy Periodontal Therapeutics Market Forecast, by Treatment 12.22.1. Systematic Antibiotics 12.22.2. Local Antibiotics 12.22.3. Others 12.23. Italy Periodontal Therapeutics Market Forecast, by End-User 12.23.1. Dental clinics 12.23.2. Hospital 12.24. Spain Periodontal Therapeutics Market Forecast, by Type 12.24.1.1. Gingivitis 12.24.1.2. Chronic periodontitis 12.24.1.3. Aggressive periodontitis 12.24.1.4. Necrotizing periodontal disease 12.25. Spain Periodontal Therapeutics Market Forecast, by Treatment 12.25.1. Systematic Antibiotics 12.25.2. Local Antibiotics 12.25.3. Others 12.26. Spain Periodontal Therapeutics Market Forecast, by End-User 12.26.1. Dental clinics 12.26.2. Hospital 12.27. Rest of Europe Periodontal Therapeutics Market Forecast, by Type 12.27.1.1. Gingivitis 12.27.1.2. Chronic periodontitis 12.27.1.3. Aggressive periodontitis 12.27.1.4. Necrotizing periodontal disease 12.28. Rest of Europe Periodontal Therapeutics Market Forecast, by Treatment 12.28.1. Systematic Antibiotics 12.28.2. Local Antibiotics 12.28.3. Others 12.29. Rest Of Europe Periodontal Therapeutics Market Forecast, by End-User 12.29.1. Dental clinics 12.29.2. Hospital 12.30. Europe Periodontal Therapeutics Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By Treatment 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Periodontal Therapeutics Market Analysis 13.1. Key Findings 13.2. Asia Pacific Periodontal Therapeutics Market Overview 13.3. Asia Pacific Periodontal Therapeutics Market Value Share Analysis, by Type 13.4. Asia Pacific Periodontal Therapeutics Market Forecast, by Type 13.4.1.1. Gingivitis 13.4.1.2. Chronic periodontitis 13.4.1.3. Aggressive periodontitis 13.4.1.4. Necrotizing periodontal disease 13.5. Asia Pacific Periodontal Therapeutics Market Value Share Analysis, by Treatment 13.6. Asia Pacific Periodontal Therapeutics Market Forecast, by Treatment 13.6.1. Systematic Antibiotics 13.6.2. Local Antibiotics 13.6.3. Others 13.7. Asia Pacific Periodontal Therapeutics Market Value Share Analysis, by End-User 13.8. Asia Pacific Periodontal Therapeutics Market Forecast, by End-User 13.8.1. Dental clinics 13.8.2. Hospital 13.9. Asia Pacific Periodontal Therapeutics Market Value Share Analysis, by Country 13.10. Asia Pacific Periodontal Therapeutics Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Periodontal Therapeutics Market Analysis, by Country 13.12. China Periodontal Therapeutics Market Forecast, by Type 13.12.1.1. Gingivitis 13.12.1.2. Chronic periodontitis 13.12.1.3. Aggressive periodontitis 13.12.1.4. Necrotizing periodontal disease 13.13. China Periodontal Therapeutics Market Forecast, by Treatment 13.13.1. Systematic Antibiotics 13.13.2. Local Antibiotics 13.13.3. Others 13.14. China Periodontal Therapeutics Market Forecast, by End-User 13.14.1. Dental clinics 13.14.2. Hospital 13.14.3. Logistics 13.15. India Periodontal Therapeutics Market Forecast, by Type 13.15.1.1. Gingivitis 13.15.1.2. Chronic periodontitis 13.15.1.3. Aggressive periodontitis 13.15.1.4. Necrotizing periodontal disease 13.16. India Periodontal Therapeutics Market Forecast, by Treatment 13.16.1. Systematic Antibiotics 13.16.2. Local Antibiotics 13.16.3. Others 13.17. India Periodontal Therapeutics Market Forecast, by End-User 13.17.1. Dental clinics 13.17.2. Hospital 13.18. Japan Periodontal Therapeutics Market Forecast, by Type 13.18.1.1. Gingivitis 13.18.1.2. Chronic periodontitis 13.18.1.3. Aggressive periodontitis 13.18.1.4. Necrotizing periodontal disease 13.19. Japan Periodontal Therapeutics Market Forecast, by Treatment 13.19.1. Systematic Antibiotics 13.19.2. Local Antibiotics 13.19.3. Others 13.20. Japan Periodontal Therapeutics Market Forecast, by End-User 13.20.1. Dental clinics 13.20.2. Hospital 13.21. ASEAN Periodontal Therapeutics Market Forecast, by Type 13.21.1.1. Gingivitis 13.21.1.2. Chronic periodontitis 13.21.1.3. Aggressive periodontitis 13.21.1.4. Necrotizing periodontal disease 13.22. ASEAN Periodontal Therapeutics Market Forecast, by Treatment 13.22.1. Systematic Antibiotics 13.22.2. Local Antibiotics 13.22.3. Others 13.23. ASEAN Periodontal Therapeutics Market Forecast, by End-User 13.23.1. Dental clinics 13.23.2. Hospital 13.24. Rest of Asia Pacific Periodontal Therapeutics Market Forecast, by Type 13.24.1.1. Gingivitis 13.24.1.2. Chronic periodontitis 13.24.1.3. Aggressive periodontitis 13.24.1.4. Necrotizing periodontal disease 13.25. Rest of Asia Pacific Periodontal Therapeutics Market Forecast, by Treatment 13.25.1. Systematic Antibiotics 13.25.2. Local Antibiotics 13.25.3. Others 13.26. Rest of Asia Pacific Periodontal Therapeutics Market Forecast, by End-User 13.26.1. Dental clinics 13.26.2. Hospital 13.27. Asia Pacific Periodontal Therapeutics Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By Treatment 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Periodontal Therapeutics Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Periodontal Therapeutics Market Overview 14.3. Middle East & Africa Periodontal Therapeutics Market Value Share Analysis, by Type 14.4. Middle East & Africa Periodontal Therapeutics Market Forecast, by Type 14.4.1.1. Gingivitis 14.4.1.2. Chronic periodontitis 14.4.1.3. Aggressive periodontitis 14.4.1.4. Necrotizing periodontal disease 14.5. Middle East & Africa Periodontal Therapeutics Market Value Share Analysis, by Treatment 14.6. Middle East & Africa Periodontal Therapeutics Market Forecast, by Treatment 14.6.1. Systematic Antibiotics 14.6.2. Local Antibiotics 14.6.3. Others 14.7. Middle East & Africa Periodontal Therapeutics Market Value Share Analysis, by End-User 14.8. Middle East & Africa Periodontal Therapeutics Market Forecast, by End-User 14.8.1. Dental clinics 14.8.2. Hospital 14.9. Middle East & Africa Periodontal Therapeutics Market Value Share Analysis, by Country 14.10. Middle East & Africa Periodontal Therapeutics Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Periodontal Therapeutics Market Analysis, by Country 14.12. GCC Periodontal Therapeutics Market Forecast, by Type 14.12.1.1. Gingivitis 14.12.1.2. Chronic periodontitis 14.12.1.3. Aggressive periodontitis 14.12.1.4. Necrotizing periodontal disease 14.13. GCC Periodontal Therapeutics Market Forecast, by Treatment 14.13.1. Systematic Antibiotics 14.13.2. Local Antibiotics 14.13.3. Others 14.14. GCC Periodontal Therapeutics Market Forecast, by End-User 14.14.1. Dental clinics 14.14.2. Hospital 14.15. South Africa Periodontal Therapeutics Market Forecast, by Type 14.15.1.1. Gingivitis 14.15.1.2. Chronic periodontitis 14.15.1.3. Aggressive periodontitis 14.15.1.4. Necrotizing periodontal disease 14.16. South Africa Periodontal Therapeutics Market Forecast, by Treatment 14.16.1. Systematic Antibiotics 14.16.2. Local Antibiotics 14.16.3. Others 14.17. South Africa Periodontal Therapeutics Market Forecast, by End-User 14.17.1. Dental clinics 14.17.2. Hospital 14.18. Rest of Middle East & Africa Periodontal Therapeutics Market Forecast, by Type 14.18.1.1. Gingivitis 14.18.1.2. Chronic periodontitis 14.18.1.3. Aggressive periodontitis 14.18.1.4. Necrotizing periodontal disease 14.19. Rest of Middle East & Africa Periodontal Therapeutics Market Forecast, by Treatment 14.19.1. Systematic Antibiotics 14.19.2. Local Antibiotics 14.19.3. Others 14.20. Rest of Middle East & Africa Periodontal Therapeutics Market Forecast, by End-User 14.20.1. Dental clinics 14.20.2. Hospital 14.21. Middle East & Africa Periodontal Therapeutics Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By Treatment 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Periodontal Therapeutics Market Analysis 15.1. Key Findings 15.2. South America Periodontal Therapeutics Market Overview 15.3. South America Periodontal Therapeutics Market Value Share Analysis, by Type 15.4. South America Periodontal Therapeutics Market Forecast, by Type 15.4.1.1. Gingivitis 15.4.1.2. Chronic periodontitis 15.4.1.3. Aggressive periodontitis 15.4.1.4. Necrotizing periodontal disease 15.5. South America Periodontal Therapeutics Market Value Share Analysis, by Treatment 15.6. South America Periodontal Therapeutics Market Forecast, by Treatment 15.6.1. Systematic Antibiotics 15.6.2. Local Antibiotics 15.6.3. Others 15.7. South America Periodontal Therapeutics Market Value Share Analysis, by End-User 15.8. South America Periodontal Therapeutics Market Forecast, by End-User 15.8.1. Dental clinics 15.8.2. Hospital 15.9. South America Periodontal Therapeutics Market Value Share Analysis, by Country 15.10. South America Periodontal Therapeutics Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Periodontal Therapeutics Market Analysis, by Country 15.12. Brazil Periodontal Therapeutics Market Forecast, by Type 15.12.1.1. Gingivitis 15.12.1.2. Chronic periodontitis 15.12.1.3. Aggressive periodontitis 15.12.1.4. Necrotizing periodontal disease 15.13. Brazil Periodontal Therapeutics Market Forecast, by Treatment 15.13.1. Systematic Antibiotics 15.13.2. Local Antibiotics 15.13.3. Others 15.14. Brazil Periodontal Therapeutics Market Forecast, by End-User 15.14.1. Dental clinics 15.14.2. Hospital 15.15. Mexico Periodontal Therapeutics Market Forecast, by Type 15.15.1.1. Gingivitis 15.15.1.2. Chronic periodontitis 15.15.1.3. Aggressive periodontitis 15.15.1.4. Necrotizing periodontal disease 15.16. Mexico Periodontal Therapeutics Market Forecast, by Treatment 15.16.1. Systematic Antibiotics 15.16.2. Local Antibiotics 15.16.3. Others 15.17. Mexico Periodontal Therapeutics Market Forecast, by End-User 15.17.1. Dental clinics 15.17.2. Hospital 15.18. Rest of South America Periodontal Therapeutics Market Forecast, by Type 15.18.1.1. Gingivitis 15.18.1.2. Chronic periodontitis 15.18.1.3. Aggressive periodontitis 15.18.1.4. Necrotizing periodontal disease 15.19. Rest of South America Periodontal Therapeutics Market Forecast, by Treatment 15.19.1. Systematic Antibiotics 15.19.2. Local Antibiotics 15.19.3. Others 15.20. Rest of South America Periodontal Therapeutics Market Forecast, by End-User 15.20.1. Dental clinics 15.20.2. Hospital 15.21. South America Periodontal Therapeutics Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By Treatment 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Den-Mat Holdings, LLC 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. 3M 16.3.3. Dexcel Pharma 16.3.4. Galderma S.A. 16.3.5. Kaken Pharmaceutical Co., Ltd. 16.3.6. Valeant Pharmaceuticals International, Inc 16.3.7. OASIS Medical 16.3.8. AFT Pharmaceuticals 16.3.9. I-Med Pharma Inc. 16.3.10. Dentsply Sirona 16.3.11. Biohorizons 16.3.12. Dexcel Pharma 16.3.13. Zimmer Biomet, 16.3.14. Emergent Biosolutions, Inc. 16.3.15. F. Hoffmann-La Roche Ltd. 16.3.16. Gilead Sciences 16.3.17. Inovio Pharmaceuticals 16.3.18. Novavax, Inc. 16.3.19. SELLAS Life Sciences Group, Inc 16.3.20. Tolmar Pharmaceuticals, Inc. 16.3.21. Eli Lilly and Company 16.3.22. Align Technology, Inc. 16.3.23. Ultradent Products Inc. 16.3.24. Nobel Biocare Services AG 16.3.25. Glidewell Laboratories 16.3.26. Mallinckrodt. 17. Primary Key Insights